Aortic stenosis: role of balloon aortic valvuloplasty.
Calcific aortic stenosis (AS) is the most frequent expression of aortic valve disease in the Western world, with an increasing prevalence as the population ages. Almost 4% of all adults 75 years of age or older have moderate or severe AS. Many patients do not undergo surgery because of prohibitive comorbidities or other high-risk features. Balloon aortic valvuloplasty (BAV) remains an option for temporary palliation and symptomatic relief in such patients. In addition, BAV continues to serve an important role as a bridge to either surgical or transcatheter aortic valve replacement in certain patients with AS requiring temporary hemodynamic stabilization.
Cardiac Catheterization Laboratory, Mount Sinai Medical Center, New York, NY 10029, USA.
Usman
U
Baber
Annapoorna S
AS
Kini
Pedro R
PR
Moreno
Samin K
SK
Sharma
D000368:Aged; D000369:Aged, 80 and over; D001021:Aortic Valve / Q000473:pathology*; D001024:Aortic Valve Stenosis / Q000209:etiology / Q000628:therapy*; D050197:Atherosclerosis / Q000209:etiology; D063126:Balloon Valvuloplasty / Q000379:methods*; D002114:Calcinosis / Q000209:etiology / Q000628:therapy*; D058385:Cardiac Valve Annuloplasty / Q000379:methods*; D002908:Chronic Disease; D019918:Heart Valve Prosthesis Implantation / Q000379:methods; D006801:Humans; D050356:Lipid Metabolism / Q000502:physiology
Aortic stenosis; Aortic valve replacement; Balloon aortic valvuloplasty; Transcatheter aortic valve replacement